AXSOME THERAPEUTICS INC: FDA GRANTS AXS-05 PRIORITY REVIEW DESIGNATION AND SETS PDUFA ACTION GOAL DATE OF APRIL 30, 2026

Reuters · 12/31/2025 12:00

Please log in to view news